Dr Agarwal’s Healthcare IPO is now open for subscription, with a price range of Rs 382-402 per share. Despite a significant OFS component and rich pricing, analysts recommend investing for the long term. The company commands a 25% market share in India’s eye care service market, benefiting from industry growth projections.
Why FIIs are dumping bluechips to hunt small & midcaps
Foreign institutional investors are shifting their focus from India’s top blue-chip stocks to a wider array of mid- and small-cap companies. This strategic repositioning is